A detailed history of Kula Investments, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Kula Investments, LLC holds 11,706 shares of ACAD stock, worth $199,821. This represents 0.05% of its overall portfolio holdings.

Number of Shares
11,706
Holding current value
$199,821
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$16.32 - $20.92 $191,041 - $244,889
11,706 New
11,706 $220 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Kula Investments, LLC Portfolio

Follow Kula Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kula Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kula Investments, LLC with notifications on news.